Published in Mayo Clin Proc on May 01, 2001
Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology (2007) 4.28
MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology (2008) 2.69
REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology (2010) 2.50
Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology (2000) 2.31
Frontotemporal brain sagging syndrome: an SIH-like presentation mimicking FTD. Neurology (2011) 2.27
Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology (2007) 2.22
Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord (2000) 2.20
Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study. Neurology (2009) 2.09
Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS. Neurology (2008) 1.78
Imaging correlates of pathology in corticobasal syndrome. Neurology (2010) 1.71
Medical records documentation of constipation preceding Parkinson disease: A case-control study. Neurology (2009) 1.64
Gray and white matter water diffusion in the syndromic variants of frontotemporal dementia. Neurology (2010) 1.57
Long-term cognitive outcomes following out-of-hospital cardiac arrest: a population-based study. Neurology (2011) 1.51
Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN. Neurology (2009) 1.48
Parkinsonism and tardive antecollis in frontotemporal dementia--increased sensitivity to newer antipsychotics? Eur J Neurol (2008) 1.47
Education and occupations preceding Parkinson disease: a population-based case-control study. Neurology (2005) 1.43
Validity of family history data on PD: evidence for a family information bias. Neurology (2003) 1.41
Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study. Mov Disord (2001) 1.35
The alpha-synuclein gene in multiple system atrophy. J Neurol Neurosurg Psychiatry (2006) 1.25
Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration? Neurology (2010) 1.25
Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals. Neurology (2006) 1.24
Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration. Neuropathol Appl Neurobiol (2010) 1.19
Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations. Neurology (2009) 1.16
Pathologically confirmed corticobasal degeneration presenting with visuospatial dysfunction. Neurology (2003) 1.13
Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy. Brain (2004) 1.12
Characterization of DCTN1 genetic variability in neurodegeneration. Neurology (2009) 1.11
Atrophy of superior cerebellar peduncle in progressive supranuclear palsy. Neurology (2003) 1.08
Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity. Neurology (2006) 1.01
Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine. Neurology (2005) 1.01
Altered functional connectivity in asymptomatic MAPT subjects: a comparison to bvFTD. Neurology (2011) 0.99
Autopsy patterns for Parkinson's disease and related disorders in Olmsted County, Minnesota. Neurology (1999) 0.98
Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites. Infect Immun (1993) 0.94
Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies. Parkinsonism Relat Disord (2011) 0.94
Time trends in the incidence of parkinsonism in Olmsted County, Minnesota. Neurology (2001) 0.93
Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN. Neurology (2011) 0.93
Neuropsychological profiles of manganese neurotoxicity. Eur J Neurol (2006) 0.92
Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. Eur J Neurol (2013) 0.92
Coexistent Lewy body disease in a case of "visual variant of Alzheimer's disease". J Neurol Neurosurg Psychiatry (2003) 0.90
Transbronchial needle aspiration staging of bronchogenic carcinoma. Am Rev Respir Dis (1986) 0.89
Transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma. Chest (1987) 0.88
Mapping the onset and progression of atrophy in familial frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry (2005) 0.88
Predicting survival in frontotemporal dementia with motor neuron disease. Neurology (2011) 0.86
Novelty seeking and introversion do not predict the long-term risk of Parkinson disease. Neurology (2010) 0.84
Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy. Eur J Neurol (2012) 0.84
Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathology. Neurocase (2005) 0.83
Clinical and imaging features of Othello's syndrome. Eur J Neurol (2011) 0.83
Acute toxic delirium. Neurotoxicity of intrathecal administration of amphotericin B. Arch Intern Med (1979) 0.81
Abnormal lung and liver uptake of gallium-67 and technetium-99m MDP in hypercalcemia of lymphoma with metastatic pulmonary calcification. Clin Nucl Med (1986) 0.81
A limited role for DJ1 in Parkinson disease susceptibility. Neurology (2004) 0.80
Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images. Eur J Neurol (2015) 0.80
Temporary worsening of parkinsonism in a patient with Parkinson's disease after treatment with paclitaxel for a metastatic grade IV adenocarcinoma. Mov Disord (1995) 0.79
Amiodarone-associated neuromyopathy: a report of four cases. Eur J Neurol (2012) 0.79
Voxel-based morphometry in patients with obsessive-compulsive behaviors in behavioral variant frontotemporal dementia. Eur J Neurol (2012) 0.79
Clinical and imaging characterization of progressive spastic dysarthria. Eur J Neurol (2013) 0.79
Amyloid burden correlates with cognitive decline in Alzheimer's disease presenting with aphasia. Eur J Neurol (2013) 0.79
Varied electrophysiologic patterns in spinocerebellar ataxia type 2. Eur J Neurol (2006) 0.75
Detection of preclinical Parkinson disease in at-risk family members with use of [123I]beta-CIT and SPECT: an exploratory study. Mayo Clin Proc (1999) 0.75
Absorption, distribution, excretion and metabolism of a single oral dose of [14C]tri-o-cresyl phosphate (TOCP) in the male rat. Toxicology (1990) 0.75
Compulsive urination as a presenting symptom of frontotemporal dementia. Eur J Neurol (2007) 0.75
Hippocampal sclerosis in a case of Alzheimer's disease-like dementia with late onset intractable epilepsy. Eur J Neurol (2003) 0.75
The corticobasal syndrome triggered by central pontine myelinolysis. Eur J Neurol (2006) 0.75
Chronic obstructive pulmonary disease and polycythemia. JAMA (1979) 0.75
Sudden behavioral disturbance in a man with a lesion in the nucleus accumbens. J Neurol (2008) 0.75
Parotid gland biopsy and 67Ga imaging correlation in systemic sarcoidosis. Chest (1987) 0.75